QIPT

Quipt Home Medical Corp._December 15, 2025 00-00000000001540013false00015400132025-12-152025-12-15 ​ ​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

​ Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 ​ December 15, 2025 Date of Report (Date of earliest event reported)

Quipt Home Medical Corp. (Exact name of registrant as specified in its charter)

British Columbia, Canada (State or other jurisdiction of incorporation) ​ 001-40413 ​ ​ ​ N/A

(Commission File Number) ​ (IRS Employer Identification No.)

​ 1019 Town Drive ​ ​ ​ ​

Wilder, Kentucky ​ 41076

(Address of principal executive offices) ​ (Zip Code)

​ (859) 878-2220 (Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ​ Securities registered pursuant to Section 12(b) of the Act: ​ Title of each class ​ ​ ​ Trading Symbol(s) ​ ​ ​ Name of each exchange on which registered

Common Shares, without Par Value ​

QIPT

​ The Nasdaq Capital Market

​ ​ ​ ​ Toronto Stock Exchange

​ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company   ☑ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐ ​ ​ ​ ​

Item 2.02. Results of Operations and Financial Condition. On December 15, 2025, Quipt Home Medical Corp. (the “Company”) issued a press release regarding the Company’s financial results for the year ended September 30, 2025. A copy of that press release is furnished as Exhibit 99.1 hereto and incorporated herein by reference. The information in this Item 2.02, including Exhibit 99.1 hereto, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information contained herein and in the accompanying exhibit is not incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such a filing. The press release includes Non-GAAP financial measures as defined in Regulation G. ​ Use of Non-GAAP Financial Information: The press release also includes the most directly comparable financial measures calculated and presented in accordance with accounting principles generally accepted in the United States (“GAAP”), information reconciling the Non-GAAP financial measures to the GAAP financial measures and a discussion of the reasons why the Company’s management believes that presentation of the Non-GAAP financial measures provides useful information to investors regarding the Company’s financial condition and results of operations. The Non-GAAP financial measures presented therein should be considered in addition to, not as a substitute for, or superior to, financial measures calculated and presented in accordance with GAAP. ​ ​ ​

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. ​ ​ ​ Description

​ ​ ​

99.1 ​ Press Release by Quipt Home Medical Corp. dated December 15, 2025.

​ ​ ​

104 ​ Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101.

​ ​ ​ ​ ​ ​

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ​ ​

​

​ Quipt Home Medical Corp.

​ ​

Date: December 15, 2025 By: /s/ Hardik Mehta

​ ​ Hardik Mehta

​ ​ Chief Financial Officer

​ ​ ​

00-00000000001540013false00015400132025-08-112025-08-11 ​ ​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

​ Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 ​ August 11, 2025 Date of Report (Date of earliest event reported)

Quipt Home Medical Corp. (Exact name of registrant as specified in its charter)

British Columbia, Canada (State or other jurisdiction of incorporation) ​ 001-40413

N/A

(Commission File Number) ​ (IRS Employer Identification No.)

​ 1019 Town Drive

​

Wilder, Kentucky ​ 41076

(Address of principal executive offices) ​ (Zip Code)

​ (859) 878-2220 (Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ​ Securities registered pursuant to Section 12(b) of the Act: ​ Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Shares, without Par Value ​

QIPT

​ The Nasdaq Capital Market

​ ​ ​ ​ Toronto Stock Exchange

​ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company   ☑ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐ ​ ​ ​ ​

Item 2.02. Results of Operations and Financial Condition. On August 11, 2025, Quipt Home Medical Corp. (the “Company”) issued a press release regarding the Company’s financial results for the quarter ended June 30, 2025. A copy of that press release is furnished as Exhibit 99.1 hereto and incorporated herein by reference. The information in this Item 2.02, including Exhibit 99.1 hereto, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information contained herein and in the accompanying exhibit is not incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such a filing. The press release includes Non-GAAP financial measures as defined in Regulation G. ​ Use of Non-GAAP Financial Information: The press release also includes the most directly comparable financial measures calculated and presented in accordance with accounting principles generally accepted in the United States (“GAAP”), information reconciling the Non-GAAP financial measures to the GAAP financial measures and a discussion of the reasons why the Company’s management believes that presentation of the Non-GAAP financial measures provides useful information to investors regarding the Company’s financial condition and results of operations. The Non-GAAP financial measures presented therein should be considered in addition to, not as a substitute for, or superior to, financial measures calculated and presented in accordance with GAAP. ​ ​ ​

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No.

Description

​ ​ ​

99.1 ​ Press Release by Quipt Home Medical Corp. dated August 11, 2025.

​ ​ ​

104 ​ Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101.

​ ​ ​ ​ ​ ​

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ​ ​

​

​ Quipt Home Medical Corp.

​ ​

Date: August 11, 2025 By: /s/ Hardik Mehta

​ ​ Hardik Mehta

​ ​ Chief Financial Officer

​ ​ ​

00-00000000001540013false00015400132025-05-122025-05-12 ​ ​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

​ Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 ​ May 12, 2025 Date of Report (Date of earliest event reported)

Quipt Home Medical Corp. (Exact name of registrant as specified in its charter)

British Columbia, Canada (State or other jurisdiction of incorporation) ​ 001-40413

N/A

(Commission File Number) ​ (IRS Employer Identification No.)

​ 1019 Town Drive

​

Wilder, Kentucky ​ 41076

(Address of principal executive offices) ​ (Zip Code)

​ (859) 878-2220 (Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ​ Securities registered pursuant to Section 12(b) of the Act: ​ Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Shares, without Par Value ​

QIPT

​ The Nasdaq Capital Market

​ ​ ​ ​ Toronto Stock Exchange

​ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company   ☑ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐ ​ ​ ​ ​

Item 2.02. Results of Operations and Financial Condition. On May 12, 2025, Quipt Home Medical Corp. (the “Company”) issued a press release regarding the Company’s financial results for the quarter ended March 31, 2025. A copy of that press release is furnished as Exhibit 99.1 hereto and incorporated herein by reference. The information in this Item 2.02, including Exhibit 99.1 hereto, is furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information contained herein and in the accompanying exhibit is not incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, except as shall be expressly set forth by specific reference in such a filing. The press release includes Non-GAAP financial measures as defined in Regulation G. ​ Use of Non-GAAP Financial Information: The press release also includes the most directly comparable financial measures calculated and presented in accordance with accounting principles generally accepted in the United States (“GAAP”), information reconciling the Non-GAAP financial measures to the GAAP financial measures and a discussion of the reasons why the Company’s management believes that presentation of the Non-GAAP financial measures provides useful information to investors regarding the Company’s financial condition and results of operations. The Non-GAAP financial measures presented therein should be considered in addition to, not as a substitute for, or superior to, financial measures calculated and presented in accordance with GAAP. ​ ​ ​

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No.

Description

​ ​ ​

99.1 ​ Press Release by Quipt Home Medical Corp. dated May 12, 2025.

​ ​ ​

104 ​ Cover Page Interactive Data File, formatted in Inline XBRL and included as Exhibit 101.

​ ​ ​ ​ ​ ​

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ​ ​

​

​ Quipt Home Medical Corp.

​ ​

Date: May 12, 2025 By: /s/ Hardik Mehta

​ ​ Hardik Mehta

​ ​ Chief Financial Officer

​ ​ ​